66.20
                                            
                                Panoramica
                                Notizia
                                Cronologia dei prezzi
                                    Catena di opzioni
                                Financials
                                    Perché HALO Giù?
                                Forum
                                Previsione
                        
                        Halozyme Therapeutics Inc Borsa (HALO) Ultime notizie
Halozyme Therapeutics (HALO) Reports Record Q3 Revenue Growth - GuruFocus
Transcript : Halozyme Therapeutics, Inc., Q3 2025 Earnings Call, Nov 03, 2025 - MarketScreener
Halozyme Q3 2025 slides: royalty revenue surges 52%, guidance raised on strong growth - Investing.com
Earnings call transcript: Halozyme Q3 2025 beats earnings expectations - Investing.com
Halozyme Rides Strong Royalty Growth To Lift Its Outlook - Finimize
Halozyme Therapeutics: Q3 Earnings Snapshot - KVUE
HALO Boosts 2025 Revenue Forecast Amid Strong Earnings Outlook - GuruFocus
Halozyme Raises 2025 Guidance After Strong Q3 Results - TipRanks
Halozyme Therapeutics, Inc. Q3 Profit Increases, Beats Estimates - Nasdaq
HALOZYME RAISES 2025 FINANCIAL GUIDANCE AND REPORTS STRONG THIRD QUARTER 2025 FINANCIAL AND OPERATING RESULTS - PR Newswire
Can Halozyme Therapeutics Inc. stock continue upward trendJuly 2025 Market Mood & Risk Managed Investment Strategies - newser.com
What insider trading reveals about Halozyme Therapeutics Inc. stockTrade Entry Report & Entry Point Strategy Guides - newser.com
Is Halozyme Therapeutics Inc. (RV7) stock dividend growth reliable2025 AllTime Highs & Daily Volume Surge Signals - newser.com
Strategies to average down on Halozyme Therapeutics Inc.Market Trend Report & Verified Stock Trade Ideas - newser.com
Tools to assess Halozyme Therapeutics Inc.’s risk profileJuly 2025 Patterns & Safe Entry Momentum Tips - newser.com
Exit strategy if you’re trapped in Halozyme Therapeutics Inc.Exit Point & AI Powered Buy/Sell Recommendations - newser.com
Will Halozyme Therapeutics Inc. (RV7) stock outperform global peersPortfolio Update Summary & Stepwise Swing Trade Plans - newser.com
Torray Investment Partners LLC Has $2.08 Million Stock Holdings in Halozyme Therapeutics, Inc. $HALO - MarketBeat
Why Halozyme Therapeutics Inc. stock is in analyst buy zone2025 AllTime Highs & Intraday High Probability Alerts - newser.com
How Halozyme Therapeutics Inc. (RV7) stock reacts to stronger dollarBreakout Watch & AI Based Buy/Sell Signal Reports - newser.com
Why Halozyme Therapeutics Inc. stock could be next big winner2025 Momentum Check & Safe Capital Preservation Plans - newser.com
Assetmark Inc. Raises Stock Holdings in Halozyme Therapeutics, Inc. $HALO - MarketBeat
Arkadios Wealth Advisors Acquires 11,457 Shares of Halozyme Therapeutics, Inc. $HALO - MarketBeat
Will Halozyme Therapeutics Inc. stock benefit from infrastructure spendingIPO Watch & Risk Managed Investment Strategies - newser.com
Will Halozyme Therapeutics Inc. price bounce be sustainableJuly 2025 Closing Moves & Free Low Drawdown Momentum Trade Ideas - newser.com
Will Halozyme Therapeutics Inc. stock benefit from upcoming earnings reportsQuarterly Portfolio Review & AI Driven Price Predictions - newser.com
Using Python tools to backtest Halozyme Therapeutics Inc. strategiesWeekly Trend Recap & Technical Pattern Based Signals - newser.com
Halozyme Therapeutics (HALO) Anticipates Strong Q3 Earnings Grow - GuruFocus
Will Halozyme Therapeutics Inc. stock see PE expansionMarket Activity Report & High Accuracy Investment Signals - newser.com
Combining price and volume data for Halozyme Therapeutics Inc.2025 Price Targets & Low Risk Entry Point Tips - newser.com
Retirement Systems of Alabama Sells 4,246 Shares of Halozyme Therapeutics, Inc. $HALO - MarketBeat
AlphaQuest LLC Purchases 5,133 Shares of Halozyme Therapeutics, Inc. $HALO - MarketBeat
HALOZYME THERAPEUTICS Earnings Preview: Recent $HALO Insider Trading, Hedge Fund Activity, and More - Quiver Quantitative
Halozyme Therapeutics, Inc. $HALO Stock Position Lowered by Hantz Financial Services Inc. - MarketBeat
Backtesting results for Halozyme Therapeutics Inc. trading strategies2025 Fundamental Recap & AI Driven Stock Reports - newser.com
        Apri su Yahoo
        |
        Apri su Google
            |
            Aperto in Finviz
        |
        Apri in MarketWatch
            |
            Aperto a EDGAR    
        |
        Aperto su Reuters
    
    
                Capitalizzazione:
                 
                  | 
                Volume (24 ore):